Open | - |
Close | - |
Volume / Avg. | 0 / 156.625K |
Day Range | - - - |
52 Wk Range | 49.240 - 94.570 |
Market Cap | $1.277B |
P/E Ratio | 23.809 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 7.4% |
Days to Cover | 7.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ligand Pharmaceuticals (NASDAQ: LGND) through any online brokerage.
Other companies in Ligand Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
The latest price target for Ligand Pharmaceuticals (NASDAQ: LGND) was reported by HC Wainwright & Co. on Thursday, February 29, 2024. The analyst firm set a price target for 144.00 expecting LGND to rise to within 12 months (a possible 99.61% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $72.14 last updated March 18, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 19, 2007 to stockholders of record on April 3, 2007.
Ligand Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Ligand Pharmaceuticals.
Ligand Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.